NCT03891303 is a clinical trial of Allogenic blood transfusion (ABT) in Blood Transfusion, sponsored by Clinic for Cardiovascular Diseases Magdalena.

Who is sponsoring NCT03891303?

NCT03891303 is sponsored by Clinic for Cardiovascular Diseases Magdalena.

What drugs are being tested in NCT03891303?

Interventions in NCT03891303: Allogenic blood transfusion (ABT).

What condition does NCT03891303 study?

NCT03891303 studies Blood Transfusion.

Is NCT03891303 still recruiting?

NCT03891303 is currently completed. Last updated 29 March 2019.

Last reviewed 2019-03-29 · How we verify

NCT03891303

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Allogenic Blood Transfusion During Elective Open Abdominal Aortic Surgery

Completed Last updated 29 March 2019

What this trial tests

trial testing Allogenic blood transfusion (ABT) in Blood Transfusion in 426 participants. Completed in 15 October 2018.

Timeline

1 January 2011

Primary endpoint
31 December 2016

15 October 2018

Quick facts

Lead sponsor	Clinic for Cardiovascular Diseases Magdalena
Status	Completed
Study type	OBSERVATIONAL
Enrollment	426
Start date	1 January 2011
Primary completion	31 December 2016
Estimated completion	15 October 2018

Drugs / interventions tested

Allogenic blood transfusion (ABT)

Conditions studied

Blood Transfusion — all drugs for Blood Transfusion →

Sponsor

Clinic for Cardiovascular Diseases Magdalena

Who can join

Adults 18 to 90, any sex, with Blood Transfusion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Open surgery on the abdominal aorta is a high risk procedure associated with an intravascular volume blood loss and thereby, with high requirement for blood and blood product transfusion. The aim of this study was to establish the rate for allogenic blood transfusion (ABT) during elective open abdominal aortic surgery and find parameters associated with ABT requirements.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Blood Transfusion

Currently open trials in the same condition.

NCT07309848 — Hip Fracture Surgery Timing and Blood Transfusion Risk in Patients on DOACs · recruiting
NCT06721455 — Modeling Blood Management and Hemolytic Risk in Pediatric Heart Surgery · recruiting
NCT06718439 — Hemoglobin Levels for Blood Transfusions During and After Surgery · NA · recruiting
NCT06142825 — Developing, Implementing and Evaluating Effective Community-facility Interactions to Improve Blood Availability and Tran · NA · active not recruiting
NCT06102590 — Oxygen Extraction-guided Transfusion · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03891303 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Clinic for Cardiovascular Diseases Magdalena
Last refreshed: 29 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03891303.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing